Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.1bn reported value -9.9% vs Q4 2021
76positions
51.0%in top 10
9 new 26 added 34 reduced 23 sold out vs Q4 2021

Options: 5 call positions ($140.0m notional), 5 put positions ($75.8m notional) – listed below, not included above.

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 7,126,711 $84.6m7.79% 7.79% AddedShares held: Q2 2021 3.8m, Q3 2021 6.0m, Q4 2021 6.4m, Q1 2022 7.1m +737.2k +737,173 11.5%
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 644,666 $76.4m7.04% 7.04% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 315.1k, Q1 2022 644.7k +329.5k +329,537 104.6%
3 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 609,939 $64.2m5.91% 5.91% ReducedShares held: Q2 2021 666.7k, Q3 2021 634.7k, Q4 2021 833.8k, Q1 2022 609.9k -223.8k -223,811 -26.8%
4 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 1,259,162 $55.5m5.11% 5.11% AddedShares held: Q2 2021 112.7k, Q3 2021 401.7k, Q4 2021 567.2k, Q1 2022 1.3m +692.0k +691,957 122.0%
5 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 292,234 $52.4m4.83% 4.83% ReducedShares held: Q2 2021 442.9k, Q3 2021 444.5k, Q4 2021 391.9k, Q1 2022 292.2k -99.7k -99,686 -25.4%
6 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 745,263 $49.4m4.55% 4.55% ReducedShares held: Q2 2021 985.7k, Q3 2021 890.8k, Q4 2021 949.2k, Q1 2022 745.3k -204.0k -203,961 -21.5%
7 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 417,172 $49.0m4.51% 4.51% AddedShares held: Q2 2021 241.8k, Q3 2021 445.2k, Q4 2021 403.7k, Q1 2022 417.2k +13.5k +13,494 3.3%
8 DANAHER CORPORATION COM DHR DHR 159,768 $46.9m4.32% 4.32% ReducedShares held: Q2 2021 204.7k, Q3 2021 147.9k, Q4 2021 170.1k, Q1 2022 159.8k -10.3k -10,285 -6.0%
9 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 4,143,602 $38.9m3.58% 3.58% AddedShares held: Q2 2021 3.8m, Q3 2021 3.6m, Q4 2021 2.3m, Q1 2022 4.1m +1.8m +1,842,104 80.0%
10 R1 RCM INC COM RCM RCM 1,361,506 $36.4m3.35% 3.35% AddedShares held: Q2 2021 770.0k, Q3 2021 764.8k, Q4 2021 733.1k, Q1 2022 1.4m +628.4k +628,374 85.7%
11 AVANTOR INC COM AVTR AVTR 995,232 $33.7m3.10% 3.10% ReducedShares held: Q2 2021 974.6k, Q3 2021 1.3m, Q4 2021 1.1m, Q1 2022 995.2k -130.2k -130,233 -11.6%
12 MASIMO CORP COM MASI MASI 208,970 $30.4m2.80% 2.80% NewShares held: Q2 2021 0, Q3 2021 67.0k, Q4 2021 0, Q1 2022 209.0k
13 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 8,980,145 $29.5m2.72% 2.72% ReducedShares held: Q2 2021 16.7m, Q3 2021 11.6m, Q4 2021 10.6m, Q1 2022 9.0m -1.6m -1,593,157 -15.1%
14 HCA HEALTHCARE INC COM HCA HCA 111,440 $27.9m2.57% 2.57% AddedShares held: Q2 2021 8.3k, Q3 2021 38.4k, Q4 2021 49.1k, Q1 2022 111.4k +62.3k +62,346 127.0%
15 ENVISTA HOLDINGS CORPORATION COM NVST NVST 569,351 $27.7m2.55% 2.55% ReducedShares held: Q2 2021 656.1k, Q3 2021 810.9k, Q4 2021 849.3k, Q1 2022 569.4k -279.9k -279,947 -33.0%
16 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 5,491,497 $22.9m2.11% 2.11% ReducedShares held: Q2 2021 5.6m, Q3 2021 6.8m, Q4 2021 6.4m, Q1 2022 5.5m -949.1k -949,075 -14.7%
17 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 636,453 $21.7m2.00% 2.00% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 592.5k, Q1 2022 636.5k +44.0k +43,975 7.4%
18 ARK ETF TR GENOMIC REV ETF ARKG ARKG 470,506 $21.6m1.99% 1.99% ReducedShares held: Q2 2021 773.5k, Q3 2021 689.5k, Q4 2021 664.5k, Q1 2022 470.5k -194.0k -193,978 -29.2%
19 FATE THERAPEUTICS INC COM FATE FATE 456,059 $17.7m1.63% 1.63% AddedShares held: Q2 2021 346.3k, Q3 2021 260.9k, Q4 2021 254.8k, Q1 2022 456.1k +201.3k +201,269 79.0%
20 BIOGEN INC COM BIIB BIIB 78,003 $16.4m1.51% 1.51% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 33.0k, Q1 2022 78.0k +45.0k +44,962 136.1%
21 MCKESSON CORP COM MCK MCK 52,375 $16.1m1.48% 1.48% ReducedShares held: Q2 2021 75.0k, Q3 2021 161.7k, Q4 2021 136.1k, Q1 2022 52.4k -83.7k -83,736 -61.5%
22 ELEVANCE HEALTH INC COM ELV ELV 32,451 $15.9m1.47% 1.47% ReducedShares held: Q2 2021 10.1k, Q3 2021 31.6k, Q4 2021 34.3k, Q1 2022 32.5k -1.8k -1,843 -5.4%
23 DEXCOM INC COM DXCM DXCM 28,404 $14.5m1.34% 1.34% AddedShares held: Q2 2021 9.5k, Q3 2021 6.4k, Q4 2021 6.4k, Q1 2022 28.4k +22.0k +22,003 343.7%
24 GUARDANT HEALTH INC COM GH GH 213,203 $14.1m1.30% 1.30% AddedShares held: Q2 2021 1.8k, Q3 2021 100.4k, Q4 2021 100.3k, Q1 2022 213.2k +112.9k +112,869 112.5%
25 IQVIA HLDGS INC COM IQV IQV 59,570 $13.8m1.27% 1.27% AddedShares held: Q2 2021 5.7k, Q3 2021 6.8k, Q4 2021 24.6k, Q1 2022 59.6k +35.0k +34,952 142.0%
26 ILLUMINA INC COM ILMN ILMN 38,759 $13.5m1.25% 1.25% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 38.8k
27 XENON PHARMACEUTICALS INC COM XENE XENE 410,021 $12.5m1.15% 1.15% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 209.5k, Q1 2022 410.0k +200.5k +200,502 95.7%
28 ICON PLC SHS ICLR ICLR 46,816 $11.4m1.05% 1.05% ReducedShares held: Q2 2021 0, Q3 2021 71.9k, Q4 2021 51.9k, Q1 2022 46.8k -5.1k -5,051 -9.7%
29 CENTENE CORP DEL COM CNC CNC 119,170 $10.0m0.92% 0.92% ReducedShares held: Q2 2021 68.0k, Q3 2021 141.1k, Q4 2021 224.6k, Q1 2022 119.2k -105.4k -105,443 -46.9%
30 LABORATORY CORP AMER HLDGS COM NEW COM NEW 37,910 $10.0m0.92% 0.92% ReducedShares held: Q2 2021 0, Q3 2021 128.3k, Q4 2021 45.5k, Q1 2022 37.9k -7.6k -7,612 -16.7%
31 LIQUIDIA CORPORATION COM NEW LQDA LQDA 1,377,490 $9.9m0.91% 0.91% ReducedShares held: Q2 2021 979.0k, Q3 2021 929.0k, Q4 2021 1.4m, Q1 2022 1.4m -70.4k -70,408 -4.9%
32 NANOSTRING TECHNOLOGIES INC COM NSTG NSTG 280,695 $9.8m0.90% 0.90% AddedShares held: Q2 2021 0, Q3 2021 168.7k, Q4 2021 265.7k, Q1 2022 280.7k +15.0k +15,000 5.7%
33 HEALTHEQUITY INC COM HQY HQY 144,140 $9.7m0.89% 0.89% ReducedShares held: Q2 2021 197.5k, Q3 2021 114.4k, Q4 2021 333.4k, Q1 2022 144.1k -189.2k -189,212 -56.8%
34 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 220,286 $9.5m0.88% 0.88% AddedShares held: Q2 2021 174.2k, Q3 2021 179.4k, Q4 2021 181.2k, Q1 2022 220.3k +39.1k +39,135 21.6%
35 QIAGEN NV SHS NEW SHS NEW 192,699 $9.4m0.87% 0.87% AddedShares held: Q2 2021 651.0k, Q3 2021 143.1k, Q4 2021 162.5k, Q1 2022 192.7k +30.2k +30,165 18.6%
36 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 52,871 $8.6m0.79% 0.79% ReducedShares held: Q2 2021 51.1k, Q3 2021 59.2k, Q4 2021 70.2k, Q1 2022 52.9k -17.4k -17,369 -24.7%
37 ORTHO CLINICAL DIAGNOSTICS H ORD SHS OCDX OCDX 445,059 $8.3m0.76% 0.76% ReducedShares held: Q2 2021 1.4m, Q3 2021 915.0k, Q4 2021 886.1k, Q1 2022 445.1k -441.1k -441,081 -49.8%
38 ARGENX SE SPONSORED ADR ARGX ARGX 23,142 $7.3m0.67% 0.67% AddedShares held: Q2 2021 0, Q3 2021 5.7k, Q4 2021 21.5k, Q1 2022 23.1k +1.6k +1,646 7.7%
39 REPLIGEN CORP COM RGEN RGEN 36,521 $6.9m0.63% 0.63% AddedShares held: Q2 2021 3.7k, Q3 2021 4.4k, Q4 2021 4.6k, Q1 2022 36.5k +31.9k +31,937 696.7%
40 SYNEOS HEALTH INC CL A INCR INCR 81,416 $6.6m0.61% 0.61% ReducedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 85.6k, Q1 2022 81.4k -4.2k -4,196 -4.9%
41 IONIS PHARMACEUTICALS INC COM IONS IONS 158,806 $5.9m0.54% 0.54% ReducedShares held: Q2 2021 442.0k, Q3 2021 450.5k, Q4 2021 384.8k, Q1 2022 158.8k -226.0k -225,983 -58.7%
42 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 100,187 $4.6m0.43% 0.43% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 63.2k, Q1 2022 100.2k +37.0k +37,024 58.6%
43 EXELIXIS INC COM EXEL EXEL 203,156 $4.6m0.42% 0.42% ReducedShares held: Q2 2021 180.0k, Q3 2021 516.3k, Q4 2021 535.7k, Q1 2022 203.2k -332.5k -332,544 -62.1%
44 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 27,047 $4.3m0.39% 0.39% ReducedShares held: Q2 2021 0, Q3 2021 113.9k, Q4 2021 73.2k, Q1 2022 27.0k -46.1k -46,122 -63.0%
45 908 DEVICES INC COM MASS MASS 217,149 $4.1m0.38% 0.38% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 217.1k
46 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,424,650 $4.1m0.38% 0.38% AddedShares held: Q2 2021 0, Q3 2021 397.9k, Q4 2021 1.1m, Q1 2022 1.4m +306.8k +306,752 27.4%
47 GOSSAMER BIO INC COM GOSS GOSS 374,723 $3.3m0.30% 0.30% AddedShares held: Q2 2021 0, Q3 2021 149.9k, Q4 2021 39.9k, Q1 2022 374.7k +334.8k +334,813 838.9%
48 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 155,743 $2.9m0.27% 0.27% ReducedShares held: Q2 2021 0, Q3 2021 160.0k, Q4 2021 194.6k, Q1 2022 155.7k -38.8k -38,846 -20.0%
49 ANAPTYSBIO INC COM ANAB ANAB 114,165 $2.8m0.26% 0.26% ReducedShares held: Q2 2021 0, Q3 2021 78.1k, Q4 2021 182.6k, Q1 2022 114.2k -68.4k -68,447 -37.5%
50 RADIUS HEALTH INC COM NEW RDUS RDUS 302,172 $2.7m0.25% 0.25% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 302.2k
51 AADI BIOSCIENCE INC COM WHWK WHWK 150,817 $2.6m0.24% 0.24% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 150.8k
52 AGILENT TECHNOLOGIES INC COM A A 19,255 $2.5m0.23% 0.23% ReducedShares held: Q2 2021 15.3k, Q3 2021 18.7k, Q4 2021 19.4k, Q1 2022 19.3k -176 -176 -0.9%
53 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 8,163 $2.5m0.23% 0.23% ReducedShares held: Q2 2021 7.7k, Q3 2021 9.4k, Q4 2021 9.8k, Q1 2022 8.2k -1.7k -1,662 -16.9%
54 MERUS N V COM MRUS MRUS 76,849 $2.0m0.19% 0.19% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 19.0k, Q1 2022 76.8k +57.8k +57,849 304.5%
55 KARUNA THERAPEUTICS INC COM COM 15,934 $2.0m0.19% 0.19% UnchangedShares held: Q2 2021 0, Q3 2021 25.0k, Q4 2021 15.9k, Q1 2022 15.9k
56 MERCK & CO INC COM MRK MRK 9,483 $2.0m0.18% 0.18% ReducedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 19.5k, Q1 2022 9.5k -10.0k -9,973 -51.3%
57 PERKINELMER INC COM RVTY RVTY 9,788 $1.7m0.16% 0.16% ReducedShares held: Q2 2021 0, Q3 2021 47.1k, Q4 2021 30.9k, Q1 2022 9.8k -21.1k -21,081 -68.3%
58 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 371,540 $1.5m0.14% 0.14% ReducedShares held: Q2 2021 473.1k, Q3 2021 398.1k, Q4 2021 401.5k, Q1 2022 371.5k -30.0k -30,000 -7.5%
59 MILESTONE PHARMACEUTICALS IN COM MIST MIST 147,165 $944.8k0.09% 0.09% UnchangedShares held: Q2 2021 0, Q3 2021 113.6k, Q4 2021 147.2k, Q1 2022 147.2k
60 ENSIGN GROUP INC COM ENSG ENSG 10,397 $936.4k0.09% 0.09% UnchangedShares held: Q2 2021 9.0k, Q3 2021 10.4k, Q4 2021 10.4k, Q1 2022 10.4k
61 HESKA CORP COM RESTRC NEW HSKA HSKA 5,836 $807.0k0.07% 0.07% AddedShares held: Q2 2021 3.4k, Q3 2021 4.5k, Q4 2021 4.5k, Q1 2022 5.8k +1.3k +1,311 29.0%
62 KODIAK SCIENCES INC COM KOD KOD 91,200 $704.1k0.06% 0.06% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 91.2k
63 ASSEMBLY BIOSCIENCES INC COM COM 280,000 $576.8k0.05% 0.05% ReducedShares held: Q2 2021 0, Q3 2021 350.0k, Q4 2021 310.0k, Q1 2022 280.0k -30.0k -30,000 -9.7%
64 SPERO THERAPEUTICS INC COM SPRO SPRO 59,639 $518.9k0.05% 0.05% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 59.6k
65 SONIDA SENIOR LIVING INC COM SNDA SNDA 15,209 $503.9k0.05% 0.05% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 15.2k, Q1 2022 15.2k
66 AC IMMUNE SA SHS ACIU ACIU 124,589 $498.4k0.05% 0.05% ReducedShares held: Q2 2021 0, Q3 2021 221.7k, Q4 2021 153.4k, Q1 2022 124.6k -28.8k -28,791 -18.8%
67 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 237,086 $488.4k0.04% 0.04% ReducedShares held: Q2 2021 0, Q3 2021 444.9k, Q4 2021 348.7k, Q1 2022 237.1k -111.6k -111,630 -32.0%
68 SURGALIGN HOLDINGS INC COM RTIX RTIX 1,573,802 $478.9k0.04% 0.04% ReducedShares held: Q2 2021 3.9m, Q3 2021 3.5m, Q4 2021 1.9m, Q1 2022 1.6m -344.9k -344,941 -18.0%
69 BIO-TECHNE CORP COM TECH TECH 1,062 $459.9k0.04% 0.04% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 1.1k
70 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 114,008 $449.2k0.04% 0.04% UnchangedShares held: Q2 2021 0, Q3 2021 114.0k, Q4 2021 114.0k, Q1 2022 114.0k
71 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 370,170 $414.6k0.04% 0.04% AddedShares held: Q2 2021 0, Q3 2021 899.6k, Q4 2021 259.5k, Q1 2022 370.2k +110.7k +110,700 42.7%
72 CYCLERION THERAPEUTICS INC COM COM 371,955 $412.9k0.04% 0.04% UnchangedShares held: Q2 2021 0, Q3 2021 372.0k, Q4 2021 372.0k, Q1 2022 372.0k
73 AVROBIO INC COM COM 295,369 $389.9k0.04% 0.04% ReducedShares held: Q2 2021 0, Q3 2021 359.5k, Q4 2021 305.0k, Q1 2022 295.4k -9.6k -9,620 -3.1%
74 ORCHARD THERAPEUTICS PLC ADS ORTX ORTX 419,581 $298.7k0.03% 0.03% UnchangedShares held: Q2 2021 0, Q3 2021 569.6k, Q4 2021 419.6k, Q1 2022 419.6k
75 GLYCOMIMETICS INC COM COM 100,579 $114.7k0.01% 0.01% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 100.0k, Q1 2022 100.6k +579 +579 0.6%
76 CLOVIS ONCOLOGY INC COM CLVS CLVS 30,000 $60.6k0.01% 0.01% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 30.0k

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
HUMANA INC HUM HUM 27,382 $12.7m27.4k shares
INTRA-CELLULAR THERAPIES INC ITCI ITCI 231,787 $12.1m231.8k shares
ARK ETF TR ARKK ARKK 119,118 $11.3m119.1k shares
MAGELLAN HEALTH INC MGLN MGLN 104,700 $9.9m104.7k shares
NATERA INC NTRA NTRA 102,071 $9.5m102.1k shares
ZOGENIX INC ZGNX ZGNX 550,966 $9.0m551.0k shares
INSULET CORP PODD PODD 30,172 $8.0m30.2k shares
CERNER CORP CERN CERN 77,543 $7.2m77.5k shares
SI-BONE INC SIBN SIBN 258,094 $5.7m258.1k shares
NEVRO CORP NVRO NVRO 66,074 $5.4m66.1k shares
AURINIA PHARMACEUTICALS INC AUPH AUPH 201,384 $4.6m201.4k shares
MARAVAI LIFESCIENCES HLDGS I MRVI MRVI 87,795 $3.7m87.8k shares
LEXICON PHARMACEUTICALS INC LXRX LXRX 797,694 $3.1m797.7k shares
CUREVAC N V CVAC CVAC 85,017 $2.9m85.0k shares
GRITSTONE BIO INC GRTS GRTS 170,125 $2.2m170.1k shares
MIRATI THERAPEUTICS INC MRTX MRTX 14,840 $2.2m14.8k shares
SANOFI SNY SNY 38,672 $1.9m38.7k shares
ESTABLISHMENT LABS HLDGS INC ESTA ESTA 25,137 $1.7m25.1k shares
MYOMO INC MYO MYO 150,000 $1.0m150.0k shares
VOCERA COMMUNICATIONS INC VCRA VCRA 14,970 $970.7k15.0k shares
LOGICBIO THERAPEUTICS INC LOGC LOGC 291,101 $672.4k291.1k shares
BROOKDALE SR LIVING INC BKD BKD 79,146 $408.4k79.1k shares
F-STAR THERAPEUTICS INC 49,933 $250.7k49.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
GLAXOSMITHKLINE PLC Call Call 1,553,700 $67.7m1.6m shares Added
INVESCO QQQ TR QQQ · Put QQQPut 180,000 $65.3m180.0k shares Reduced
ASTRAZENECA PLC Call Call 572,300 $38.0m572.3k shares Unchanged
BIOGEN INC BIIB · Call BIIBCall 140,000 $29.5m140.0k shares New
ISHARES INC EWT · Put EWTPut 100,000 $6.1m100.0k shares New
MERCK & CO INC MRK · Call MRKCall 48,700 $4.0m48.7k shares Unchanged
PROGYNY INC PGNY · Put PGNYPut 50,000 $2.6m50.0k shares Unchanged
KODIAK SCIENCES INC KOD · Put KODPut 181,200 $1.4m181.2k shares New
TEVA PHARMACEUTICAL INDS LTD Call Call 92,900 $872.3k92.9k shares Reduced
ISHARES TR IWO · Put IWOPut 1,700 $434.8k1.7k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17